Medpace Holdings Pre-Tax Profit Margin 2014-2024 | MEDP

Current and historical pre-tax profit margin for Medpace Holdings (MEDP) from 2014 to 2024. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. Medpace Holdings pre-tax profit margin for the three months ending September 30, 2024 was .
Medpace Holdings Pre-Tax Profit Margin Historical Data
Date TTM Revenue TTM Pre-Tax Income Pre-Tax Margin
2024-09-30 $2.07B $0.43B 20.92%
2024-06-30 $2.03B $0.40B 19.57%
2024-03-31 $1.96B $0.36B 18.50%
2023-12-31 $1.89B $0.34B 17.82%
2023-09-30 $1.78B $0.32B 17.91%
2023-06-30 $1.67B $0.32B 19.01%
2023-03-31 $1.56B $0.30B 19.45%
2022-12-31 $1.46B $0.28B 19.38%
2022-09-30 $1.38B $0.27B 19.27%
2022-06-30 $1.29B $0.24B 18.49%
2022-03-31 $1.21B $0.22B 18.04%
2021-12-31 $1.14B $0.20B 17.76%
2021-09-30 $1.09B $0.20B 18.46%
2021-06-30 $1.03B $0.19B 18.87%
2021-03-31 $0.96B $0.18B 18.95%
2020-12-31 $0.93B $0.17B 18.14%
2020-09-30 $0.90B $0.15B 16.63%
2020-06-30 $0.88B $0.13B 14.85%
2020-03-31 $0.89B $0.14B 15.15%
2019-12-31 $0.86B $0.12B 14.40%
2019-09-30 $0.82B $0.12B 14.22%
2019-06-30 $0.79B $0.11B 14.38%
2019-03-31 $0.74B $0.10B 13.61%
2018-12-31 $0.70B $0.09B 13.35%
2018-09-30 $0.63B $0.08B 12.64%
2018-06-30 $0.56B $0.07B 12.39%
2018-03-31 $0.49B $0.06B 12.37%
2017-12-31 $0.44B $0.06B 13.04%
2017-09-30 $0.43B $0.04B 9.95%
2017-06-30 $0.43B $0.04B 8.39%
2017-03-31 $0.43B $0.03B 6.99%
2016-12-31 $0.42B $0.02B 5.21%
2016-06-30 $0.30B $0.02B 5.03%
Sector Industry Market Cap Revenue
Medical Medical Services $9.789B $1.886B
Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $91.424B 11.34
Cencora (COR) United States $47.484B 17.51
DiDi Global (DIDIY) China $23.330B 0.00
Natera (NTRA) United States $21.401B 0.00
ICON (ICLR) Ireland $16.136B 14.37
Viatris (VTRS) United States $15.576B 4.80
Avantor (AVTR) United States $13.422B 20.12
Revvity (RVTY) United States $13.376B 23.24
CochLear (CHEOY) Australia $12.844B 0.00
BioMerieux (BMXMF) France $12.666B 0.00
Solventum (SOLV) United States $11.583B 0.00
Doximity (DOCS) United States $9.620B 56.63
Charles River Laboratories (CRL) United States $9.516B 18.39
HealthEquity (HQY) United States $8.966B 48.66
Sonic Healthcare (SKHHY) Australia $8.758B 0.00
Bausch + Lomb (BLCO) Canada $6.885B 32.05
Life Times (LTH) United States $5.085B 33.66
Sotera Health (SHC) United States $3.855B 20.62
Organon (OGN) United States $3.757B 3.79
BrightSpring Health Services (BTSG) United States $3.247B 69.07
Surgery Partners (SGRY) United States $2.892B 32.97
PACS (PACS) United States $2.606B 0.00
Concentras Parent (CON) United States $2.581B 0.00
Ardent Health Partners (ARDT) United States $2.375B 0.00
Premier (PINC) United States $2.143B 11.15
Alignment Healthcare (ALHC) United States $2.126B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
GeneDx Holdings (WGS) United States $1.952B 0.00
GoodRx Holdings (GDRX) United States $1.616B 42.40
Teladoc Health (TDOC) United States $1.537B 0.00
Pediatrix Medical (MD) United States $1.255B 12.28
CareDx (CDNA) United States $1.183B 0.00
Progyny (PGNY) United States $1.164B 23.57
Establishment Labs Holdings (ESTA) $1.050B 0.00
AMN Healthcare Services Inc (AMN) United States $0.954B 6.46
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
Embecta (EMBC) United States $0.778B 5.18
SBC Medicals (SBC) United States $0.677B 0.00
Agilon Health (AGL) United States $0.655B 0.00
InnovAge Holding (INNV) United States $0.647B 0.00
Auna S.A (AUNA) Luxembourg $0.536B 0.00
Sonida Senior Living (SNDA) United States $0.425B 0.00
DocGo (DCGO) United States $0.410B 15.46
Enhabit (EHAB) United States $0.366B 31.61
COMPASS Pathways (CMPS) United Kingdom $0.326B 0.00
LifeMD (LFMD) United States $0.241B 0.00
ModivCare (MODV) United States $0.223B 12.09
Sera Prognostics (SERA) United States $0.209B 0.00
Beauty Health (SKIN) United States $0.200B 0.00
Biodesix (BDSX) United States $0.180B 0.00
Nutex Health (NUTX) United States $0.156B 0.00
Ascend Wellness Holdings (AAWH) United States $0.100B 0.00
So-Young (SY) China $0.092B 22.25
MultiPlan (MPLN) United States $0.084B 0.00
Singular Genomics Systems (OMIC) United States $0.054B 0.00
OncoCyte (OCX) United States $0.043B 0.00
NeueHealth (NEUE) United States $0.041B 1.08
Co-Diagnostics (CODX) United States $0.034B 0.00
Pheton Holdings (PTHL) China $0.030B 0.00
IceCure Medical (ICCM) Israel $0.028B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.020B 0.00
Oncology Institute (TOI) United States $0.014B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
XWELL (XWEL) United States $0.008B 0.00
Intelligent Bio Solutions (INBS) United States $0.006B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00